Enoticumab
Tools
Actions
General
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Pashihiko (talk | contribs) at 07:17, 31 March 2017. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | DLL4 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
KEGG |
|
Enoticumab (INN) is a human monoclonal antibody that binds to DLL4. It acts as an immunomodulator.[1]
References
- ^ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information. 26 (2).
Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems | |||||||||
---|---|---|---|---|---|---|---|---|---|
Bone |
| ||||||||
Musculoskeletal |
| ||||||||
Circulatory |
| ||||||||
Neurologic |
| ||||||||
Angiogenesis inhibitor |
| ||||||||
Growth factor |
| ||||||||
|
This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Chemicals that do not have a ChemSpider ID assigned
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a monoclonal antibody
- All stub articles